Contract 75A50121C00025
Becton, Dickinson And Company · Department Of Health And Human Services · September 30, 2021
Becton, Dickinson And Company was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 30, 2021 for $18.25 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Sparks Glencoe, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 18, 2024. If all options are exercised, the contract could reach $33.79 million.
Contract details
- PIID
- 75A50121C00025
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Drugs And Biologicals
- Place of performance
- Sparks Glencoe, MD
- First action
- September 30, 2021
- Latest action
- September 18, 2024
Description
DEOBLIGATE FUNDS ON CLIN 0006 BY $6,501,614.13 AND UPDATE POP OF CLIN 0006 TO END ON 9/30/2024.
Modification timeline
-
September 18, 2024Mod P00012 · Funding Only Action$33.79M
-
September 30, 2021Base awardBECTON DICKENSON: MULTIPLEXED RESPIRATORY PANEL TESTS FOR THE BD VERITOR, THE BD MAX, AND THE BD COR SYSTEMS$40.29M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50121C00025?
Contract 75A50121C00025 is a federal contract awarded to Becton, Dickinson And Company by Department Of Health And Human Services on September 30, 2021 for $18.25 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50121C00025?
Becton, Dickinson And Company won contract 75A50121C00025 from Department Of Health And Human Services.
How much is contract 75A50121C00025 worth?
Contract 75A50121C00025 has obligated $18.25 million to date, with a total potential value of $33.79 million if all options are exercised.